| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2023-01-19 FY | 2022-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | $220.09K | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $13.46M | $10.96M | $7.63M | – | $2.70M |
| R&D | $4.10M | $4.21M | $4.08M | $3.00M | $392.86K |
| SG&A | $9.35M | $6.75M | $3.55M | – | $2.31M |
| Operating Income | -$13.46M | -$10.96M | -$7.63M | – | -$2.70M |
| Interest Expense | – | – | – | – | $40.19K |
| Tax Expense | – | – | – | – | – |
| Net Income | -$13.24M | -$10.65M | -$8.36M | – | -$6.71M |
| EPS (basic) | -6.6400 | -8.7300 | -0.6200 | – | -0.8500 |
| EPS (diluted) | -6.6400 | -8.7300 | -0.6200 | – | -0.8500 |
| Shares (diluted) | $1.99M | $1.22M | $13.49M | – | $7.89M |